A triplex penthouse that once belonged to incarcerated ImClone co-founder Sam Waksal has been sold to A.J. Agarwal, a senior managing director of the mighty Blackstone Group.
According to the deed, he paid $7 million for the 5,800-square-foot apartment, $495,000 less than the latest asking price.
Marvin and Susan Numeroff, who bought the place from Read More
It’s a good thing to be king-as a certain disgraced diva might tell us-but not always such a good thing to be queen.
Even Martha Stewart’s advocates found her conduct difficult to defend as she faced sentencing and, perhaps, the ruin of the company she has spent her life building. Yet the government brought Read More
One of the more engrossing and amusing moments in the Martha Stewart trial-a spectacle that has produced precious little comic relief thusfar-occurred over a simple dash. The dash in question appeared on the same sheet of paper listing Ms. Stewart’s bountiful stock portfolio as the infamous notation “@60,” which had been penned beside the entry Read More
Those who attend celebrity trials such as Martha Stewart’s do so with greater and lesser degrees of urgency. At one end of the spectrum, there are the people who need to be there. The celebrity on the hot seat. His or her high-priced lawyers. And the government, or whoever is trying to expose their sins Read More
Rarely before has a successful businesswoman, or businessman for that matter, with an upstanding reputation been subject to a thrashing like the one Martha Stewart has been receiving in the media. Ever since suggestions surfaced that Ms. Stewart may have engaged in insider trading in shares of ImClone, the editors and owners of the New Read More
On Dec. 5, 2001, ImClone Systems, a biotech company that was seeking Food and Drug Administration approval for a promising anti-cancer drug called Erbitux, saw its stock peak at a price of $74 a share and begin an earthward trajectory.
On the evening of Dec. 6, ImClone’s chief executive, Sam Waksal, 54, threw his annual Read More
